Table 1.

Key themes highlighting survivors’ and caregivers’ barriers and facilitators to adherence to secondary prevention medications classified according to perceptions and practicalities.

Sample characteristics	N	Median range
Total participants identified in posts	84
Number of posts in the forum/ participant		16 (1–4932)
Number of posts about secondary prevention medications/ participant		1 (1–37)
Age at stroke
Survivor		50 (32–72)
Patient by caregiver		66 (46–91)
Gender
Male—survivor	20
Female—survivor	26
Not known—survivor	3
Male—patient talked about by caregiver	20
Female—patient talked about by caregiver	12
Unknown gender and unknown identity	3
Identity person posting
Stroke survivor	49
Caregiver	33
Not known	2
Years since stroke
(0–12 months)	37
(1–5 years)	25
(6–10 years)	4
(11–15 years)	2
(15+ years)	1
Unknown	15
Caregiver identity
Daughter/son	20
Spouse	9
Other (/in-law/ sister)	3
Unknown	1